Pharmaceuticals, namely, a partial agonist of N-methyl-D-aspartame (NMDA) receptors at low dose and a partial antagonist of NMDA at high dose, an inhibitor of microglial activation, and a modulator of NMDA receptors; antibiotics; pharmaceuticals and antibiotics for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; pharmaceuticals and antibiotics for reversing the damage caused by concussion or traumatic brain injury

REAGENTS, CELLS, AND CHEMICALS FOR DETECTING OR MEASURING THE PRESENCE, PHYSICAL STATE, ENVIRONMENT, DISTRIBUTION, OR ACTIVITY OF ONE OR MORE MOLECULES ON, WITH, OR BETWEEN CELLS; KITS CONTAINING REAGENTS, CELLS, AND CHEMICAL FOR DETECTING OR MEASURING THE PRESENCE, PHYSICAL STATE, ENVIRONMENT, DISTRIBUTION, OR ACTIVITY OF ONE OR MORE MOLECULES ON, WITHIN, OR BETWEEN CELLS, ALL FOR SCIENTIFIC OR MEDICAL RESEARCH PURPOSES